RNAi, a new therapeutic strategy against viral infection.
about
Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNAInsight into virus encapsulation mechanism through in silico interaction study between coat protein and RNA operator loops of Sesbania mosaic virus.An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation.Short hairpin RNA targeting 2B gene of coxsackievirus B3 exhibits potential antiviral effects both in vitro and in vivo.Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D geneAntiviral applications of RNAi for coronavirus.Current approaches on viral infection: proteomics and functional validations.Potential vaccines and post-exposure treatments for filovirus infections.Engineering silkworms for resistance to baculovirus through multigene RNA interference.RNA interference and antiviral therapy.Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.Cloning and characterization of the shell matrix protein Shematrin in scallop Chlamys farreri.Precise and efficient siRNA design: a key point in competent gene silencing.Silencing Estrogen Receptor-β with siRNA in Cultured Cells.SiRNA-mediated IGF-1R inhibition sensitizes human colon cancer SW480 cells to radiation.Positional effects and strand preference of RNA interference against hepatitis C virus target sequences.Inhibition of herpes simplex virus type 1 by small interfering RNA.Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy.
P2860
Q28478596-44B1BF27-D6D1-4967-B383-9D50C2F6EC12Q30386698-AD899CC9-B26D-412D-8181-038B8C2034C1Q31066444-C602C100-C70B-4B4D-BFFD-E9BAD1489EFFQ34366003-B7395C38-B82E-4820-B817-6C2F1EDF087BQ34990686-4A5CB225-CD0B-468A-87D8-C9F62B1636B2Q35861780-322C06E5-962B-42D0-ABAF-DFCAA58C8B4AQ36376425-D4779D11-B5DB-4087-AE2D-B2F199A3CF79Q36404090-1AB5B7D6-4E3B-474A-9CF8-060C6BD98C5FQ36404178-F04FC753-D339-47E4-ACF7-ABB538CD9F6BQ36480424-3C77186E-A8E6-447B-A764-FC3269A712BDQ36944914-F890FA2C-0E19-477D-9AA0-81BAE6641B45Q37001506-C1A3366E-8132-4859-B5F4-B2C87505E446Q38305944-E70ADC5E-28B7-461A-AE37-C4F1D61EF54CQ38778452-61B7B823-DB86-40EC-B8EF-C52F1616F67FQ38818360-8E96C929-ABC1-4322-AE0E-447F7EF4AD81Q39764987-303EE200-C4A3-4FA6-B4F2-4E658C3F540EQ40170241-8DEA92EC-9948-4A0A-9DDE-8BA79E736A18Q45399431-DE68306C-7A73-44AC-B2E6-2E3C9F2DA85DQ55259180-A95423F5-A63D-46ED-AC04-D46DCA1D064C
P2860
RNAi, a new therapeutic strategy against viral infection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
RNAi, a new therapeutic strategy against viral infection.
@ast
RNAi, a new therapeutic strategy against viral infection.
@en
type
label
RNAi, a new therapeutic strategy against viral infection.
@ast
RNAi, a new therapeutic strategy against viral infection.
@en
prefLabel
RNAi, a new therapeutic strategy against viral infection.
@ast
RNAi, a new therapeutic strategy against viral infection.
@en
P2860
P356
P1433
P1476
RNAi, a new therapeutic strategy against viral infection.
@en
P2093
Fischer L Tan
James Q Yin
P2860
P2888
P304
P356
10.1038/SJ.CR.7290248
P577
2004-12-01T00:00:00Z